Join
Live feed
·
INSIDERFilingvia Quantisnow
Cue Biopharma Inc. logo

Chief Legal Compliance Officer Ray Sumita converted options into 18,196 shares and sold $265,628 worth of shares (8,829 units at $30.09), increasing direct ownership by 9% to 118,545 units (SEC Form 4) to satisfy tax liability

ByQuantisnow·Wall Street's wire, on your screen.
CUE· Cue Biopharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CUE (Cue Biopharma Inc.) and more on Quantisnow.